An Observational Study of Survival in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After 1, 3, and 5 Years of Tyrosine Kinase Inhibitor (TKI) Therapy (SIMPLICITY)

2018 ◽  
Vol 18 ◽  
pp. S229
Author(s):  
Mauricette Michallet ◽  
Jorge Cortes ◽  
Carlo Gambacorti-Passerini ◽  
Rüdiger Hehlmann ◽  
Loretta A. Williams ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Observational Study ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Chronic Phase

Comparing the efficacy of generic Imatinib formulations with the original Imatinib as the frontline tyrosine kinase inhibitor in chronic phase chronic myeloid leukemia.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e18024-e18024 ◽  
Author(s):  
Fatih Demirkan ◽  
Omur Gokmen Gokmen Sevindik ◽  
Aysegul Karaman ◽  
Inci Alacacioglu ◽  
Serife Medeni Solmaz ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Chronic Phase
Sign in / Sign up

Export Citation Format

Share Document